SEP 11, 2026 · JOURNAL ARTICLE
Conjunctival reactive cutaneous capillary endothelial proliferation induced by camrelizumab in an esophageal cancer patient: a case report and literature review
Frontiers in Oncology
A single case report describing a novel adverse event manifestation; raises awareness of a rare toxicity but provides no comparative data or epidemiological evidence.
Reported
Patient age64 years
Grade of conjunctival RCCEPGrade 3
Camrelizumab cycles completed bef…3